VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
KMPB
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
KMPBKemper Corporation 5.875% Fixed
$24.63$1.5B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksKMPBFinancials

Kemper Corporation 5.875% Fixed (KMPB) Income Statement

30Y historyFree accessUpdated daily

Revenue contracted 11% year-over-year in 2026Q2, and the combined ratio deteriorated to 102.7% in 2025Q3, reflecting underwriting losses.

Income StatementBalance SheetCash FlowRatios

KMPB Income Statement

Annual statement

KMPB Income Statement

Kemper Corporation 5.875% Fixed (KMPB) annual income statement — 30-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Revenue4.57B4.8B4.63B4.95B5.45B5.61B5.18B5.02B3.69B2.67B2.52B2.34B2.2B2.43B2.46B2.5B2.64B2.93B2.74B2.9B2.86B2.83B2.82B2.67B2.3B2.53B1.95B1.81B2.09B1.56B1.57B
Revenue Growth %-4.13%3.62%-6.32%-9.27%-2.92%8.42%3.16%36.13%38.17%5.83%7.74%6.56%-9.47%-1.45%-1.31%-5.58%-9.92%6.97%-5.54%1.6%0.99%0.36%5.62%16.14%-9.3%29.73%7.7%-13.05%34.12%-1.17%5.44%
Medical Costs & Claims2.92B3.38B4.04B3.82B5.66B5.26B4.02B3.83B2.92B2.23B2.16B1.83B1.59B1.7B1.94B2B1.65B1.74B1.77B2.28B2.22B2.29B2.49B2.58B2.16B1.84B1.65B1.46B1.29B1.26B1.29B
Medical Cost Ratio %63.84%70.32%87.28%77.25%103.88%93.68%77.58%76.3%79.2%83.54%85.82%78.07%72.2%70.2%78.74%80.22%62.33%59.3%64.37%78.47%77.72%80.77%88.4%96.85%94.12%72.69%84.43%80.65%61.82%81.05%81.71%
Gross Profit1.65B1.43B589.4M1.13B-211.3M354.8M1.16B1.19B766.9M439.2M357.5M513.4M610.7M723.1M523.5M493.6M995.3M1.19B977M624.9M636.5M544M326.9M84.2M135.2M691.9M304.1M350.9M796.4M294.8M287.8M
Gross Margin %36.16%29.68%12.72%22.75%-3.88%6.32%22.42%23.7%20.8%16.46%14.18%21.93%27.8%29.8%21.26%19.78%37.67%40.7%35.63%21.53%22.28%19.23%11.6%3.15%5.88%27.31%15.57%19.35%38.18%18.95%18.29%
Gross Profit Growth %-141.77%-47.62%632.56%-159.55%-69.44%-2.45%55.17%74.61%22.85%-30.37%-15.93%-15.54%38.13%6.06%-50.41%-16.63%22.2%56.34%-1.82%17%66.41%288.24%-37.72%-80.46%127.52%-13.34%-55.94%170.15%2.43%-80.72%
Operating Expenses2.18B1.26B200.9M1.47B159.7M604.2M650.8M528.4M567.8M278.1M354M413.1M450.5M408.7M401.1M425.3M758.6M964.3M1.07B398.1M266.5M232.4M213.1M199.9M159.8M149.4M-1.5B113.9M109.3M-1.13B-1.17B
OpEx / Revenue %47.56%26.34%4.34%29.77%2.93%10.76%12.57%10.53%15.4%10.42%14.04%17.65%20.51%16.84%16.29%17.05%28.71%32.87%38.91%13.71%9.33%8.21%7.56%7.49%6.95%5.9%-76.65%6.28%5.24%-72.7%-74.4%
Depreciation & Amortization83.6M74.3M53.7M58.6M70.9M99.8M55M62.5M171.9M18.2M19.5M28.9M23.2M25.7M23.3M22.3M25.5M344.3M353.5M357.4M364.8M11.6M12.6M11.4M245.6M189.6M12.1M163.1M149.3M167.4M170.1M
Combined Ratio %111.4%96.65%91.61%107.02%106.81%104.44%90.15%86.82%94.6%93.96%99.86%95.72%92.71%87.04%95.03%97.26%91.04%92.17%103.28%92.19%87.05%88.99%95.96%104.33%101.07%78.59%7.78%86.93%67.06%8.35%7.31%
Operating Income-521.5M160.7M388.5M-347.1M-371M-249.4M510.1M661.6M199.1M161.1M3.5M100.3M160.2M314.4M122.4M68.3M236.7M229.6M-90M226.8M370M311.6M113.8M-115.7M-24.6M542.5M1.8B237M687.1M1.43B1.46B
Operating Margin %-11.4%3.35%8.39%-7.02%-6.81%-4.44%9.85%13.18%5.4%6.04%0.14%4.28%7.29%12.96%4.97%2.74%8.96%7.83%-3.28%7.81%12.95%11.01%4.04%-4.33%-1.07%21.41%92.22%13.07%32.94%91.65%92.69%
Operating Income Growth %--58.64%211.93%6.44%-48.76%-148.89%-22.9%232.3%23.59%4502.86%-96.51%-37.39%-49.05%156.86%79.21%-71.14%3.09%355.11%-139.68%-38.7%18.74%173.81%198.36%-370.33%-104.53%-69.88%660.04%-65.51%-51.8%-2.27%5.56%
EBITDA-437.9M235M442.2M-288.5M-300.1M-149.6M565.1M724.1M371M179.3M23M129.2M183.4M340.1M145.7M90.6M262.2M573.9M263.5M584.2M734.8M323.2M126.4M-104.3M221M732.1M1.81B400.1M836.4M1.59B1.63B
EBITDA Margin %-9.58%4.9%9.55%-5.83%-5.51%-2.66%10.91%14.42%10.06%6.72%0.91%5.52%8.35%14.02%5.92%3.63%9.92%19.56%9.61%20.12%25.72%11.42%4.48%-3.91%9.62%28.89%92.84%22.06%40.1%102.42%103.49%
Interest Expense36.3M38.5M56.9M56.1M54.7M43.6M36M42.5M43.4M34.9M44.4M46.5M46.9M38.1M37.6M36.9M68.3M241.6M321.3M398.1M62.5M64M57.4M45.3M26.9M22.2M151.9M113.9M109.3M129.8M115.1M
Non-Operating Income2.2M-38.5M-56.9M-56.1M-54.7M-43.7M-36M-42.5M-43.4M-34.9M-44.4M-46.5M-46.9M-38.1M-37.6M-36.9M-68.3M-241.6M-321.3M-398.1M-62.5M-64M-279.1M-319.9M-26.9M-22.2M1.65B-113.9M-109.3M1.3B1.34B
Pretax Income-521.5M160.7M388.5M-347.1M-371M-249.3M510.1M661.6M199.1M161.1M3.5M100.3M160.2M314.4M122.4M68.3M236.7M229.6M-90M226.8M370M311.6M335.5M158.9M-24.6M542.5M145.4M237M687.1M165M172.7M
Pretax Margin %-11.4%3.35%8.39%-7.02%-6.81%-4.44%9.85%13.18%5.4%6.04%0.14%4.28%7.29%12.96%4.97%2.74%8.96%7.83%-3.28%7.81%12.95%11.01%11.9%5.95%-1.07%21.41%7.44%13.07%32.94%10.61%10.97%
Income Tax-16.9M28.1M76M-74.8M-84.4M-125.6M100.2M130.5M10.7M41.2M-9.2M20.1M47.6M99.9M30.6M6.6M67.5M66.4M-46.2M49.9M115M80.2M98.9M34.1M-18.3M190.3M54.4M77.9M238.6M47.1M40.2M
Effective Tax Rate %3.24%17.49%19.56%21.55%22.75%50.38%19.64%19.72%5.37%25.57%-262.86%20.04%29.71%31.77%25%9.66%28.52%28.92%51.33%22%31.08%25.74%29.48%21.46%74.39%35.08%37.41%32.87%34.73%28.55%23.28%
Net Income-495.5M143.3M317.8M-272.1M-286.6M-123.7M409.9M531.1M190.1M120.9M16.8M85.7M114.5M217.7M103.4M74.5M184.6M164.7M-29.6M205.4M283.1M255.5M240.2M123.6M-8.2M380.9M91M201M510.8M117.9M132.5M
Net Margin %-10.83%2.99%6.86%-5.5%-5.26%-2.2%7.92%10.58%5.15%4.53%0.67%3.66%5.21%8.97%4.2%2.99%6.99%5.61%-1.08%7.08%9.91%9.03%8.52%4.63%-0.36%15.03%4.66%11.08%24.49%7.58%8.42%
Net Income Growth %-244.29%-54.91%216.8%5.06%-131.69%-130.18%-22.82%179.38%57.24%619.64%-80.4%-25.15%-47.4%110.54%38.79%-59.64%12.08%656.42%-114.41%-27.45%10.8%6.37%94.34%1607.32%-102.15%318.57%-54.73%-60.65%333.25%-11.02%-12.02%
EPS (Diluted)-8.422.294.91-4.25-4.49-1.886.147.963.242.330.331.652.123.801.741.382.982.64-0.473.124.153.673.481.82-0.125.601.322.746.511.561.74
EPS Growth %-258.36%-53.36%215.53%5.35%-138.83%-130.62%-22.86%145.68%39.06%606.06%-80%-22.17%-44.21%118.39%26.09%-53.69%12.88%661.7%-115.06%-24.82%13.08%5.46%91.21%1616.67%-102.14%324.24%-51.82%-57.91%317.31%-10.34%-5.95%
EPS (Basic)-2.314.95-4.25-4.49-1.886.248.043.272.340.331.652.123.811.751.382.982.64-0.473.134.173.703.511.83-0.125.641.322.766.551.581.76
Diluted Shares Outstanding58.87M62.61M64.78M64.03M63.83M64.26M66.73M66.55M58.75M51.58M51.21M51.68M53.87M56.98M59.43M60.26M61.77M62.16M62.68M65.83M68.22M69.62M69.02M67.91M68.33M68.02M68.94M73.36M78.46M75.58M76.15M

Key Metrics

Growth RegimeDecelerating
ProfitabilityStrained
Balance SheetAdequate
Cash FlowDeteriorating
Top Statement Risk

Underwriting losses and reserve adequacy

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Premium Growth Stalls Amidst Rate Hikes

Kemper's revenue contracted 11% year-over-year in 2026Q2, per the latest income statement, with sequential declines suggesting a softening market or portfolio pruning.

Revenue fell from $1.2B in 2025Q3 to $1.1B by 2026Q2, a 5.7% sequential drop, and year-over-year growth turned negative at -11.0% in 2026Q2. This deceleration follows a period of modest growth in 2025, indicating that Kemper may be shedding unprofitable policies or facing competitive pressures. The sustained revenue decline, if it continues, could signal a shrinking underwriting base, which would pressure future earnings.

Combined Ratio Deteriorates Sharply

Kemper's combined ratio spiked to 102.7% in 2025Q3, as reported in financial statements, indicating underwriting losses that reversed prior profitability.

After a profitable 2024 with combined ratios around 92%, Kemper's combined ratio deteriorated to 100.7% in 2026Q1 and 101.2% in 2025Q4, with 2025Q3 hitting 102.7%. This suggests that loss costs are outpacing earned premiums, possibly due to higher catastrophe losses or adverse reserve development. The trend implies that underwriting is no longer contributing to earnings, and the company is relying on investment income to offset these losses.

Reserve Releases Mask Underlying Deterioration

Despite reported combined ratios above 100% in recent quarters, prior-year reserve releases may have artificially supported earnings, as suggested by the gap between loss and combined ratios.

In 2024Q4, the loss ratio was 114.8% but the combined ratio was 89.9%, implying a negative expense ratio or significant reserve releases. This indicates that favorable prior-year development was inflating underwriting results. As those releases fade, the underlying loss ratio appears to be worsening, with 2025Q3 showing a 100% loss ratio. Investors should monitor reserve adequacy, as future adverse development could further strain earnings.

Investment Income Not Disclosed, Earnings Volatile

Investment income is not separately reported in the provided data, but net income swung from $99.7M in 2025Q1 to -$464.8M in 2026Q2, indicating significant non-operating volatility.

The absence of investment income figures limits analysis, but the dramatic swing in net income—from positive $72.6M in 2025Q2 to a loss of $464.8M in 2026Q2—suggests that investment losses or impairments may be driving the downturn. Given the fixed-rate nature of the preferred stock (KMPB), the company's investment portfolio yield is critical to covering dividend obligations. The lack of disclosure warrants further investigation into the composition and performance of the investment portfolio.

2026Q2 Marks a Turning Point

The 2026Q2 net loss of $464.8M, per the income statement, represents a dramatic inflection from prior profitability, with operating income of -$467.0M signaling a fundamental shift.

Kemper's operating income collapsed from $119.8M in 2025Q1 to -$467.0M in 2026Q2, a swing of nearly $587M. This inflection point suggests a major event, such as a catastrophic loss, a change in reserve estimates, or a strategic repositioning. The magnitude of the loss is far beyond typical quarterly fluctuations, indicating that the company's earnings power has been severely impaired, and the sustainability of its dividend on the preferred shares may be at risk.

Earnings Quality Questioned by One-Time Items

Kemper's reported earnings may be overstated by favorable prior-year reserve development, as evidenced by combined ratios below loss ratios in 2024, raising questions about underlying profitability.

The discrepancy between loss ratios above 100% and combined ratios below 100% in 2024 suggests that reserve releases were masking underlying underwriting losses. If these releases are non-recurring, the true underwriting performance is worse than reported. Additionally, the 2026Q2 loss could be a one-time charge, but without disclosure, investors should be cautious about extrapolating future earnings. The company's reliance on investment income and reserve releases to achieve profitability appears fragile, and the recent deterioration may indicate a structural problem.

KMPB — Frequently Asked Questions

Quick answers to the most common questions about buying KMPB stock.

What was Kemper Corporation 5.875% Fixed's (KMPB) revenue in 2025?

For fiscal year 2025, Kemper Corporation 5.875% Fixed (KMPB) reported total revenue of $4.80B. This represents a 205.0% increase compared to $1.57B in 1996.

Is Kemper Corporation 5.875% Fixed (KMPB) profitable?

Kemper Corporation 5.875% Fixed (KMPB) is profitable, generating $143.3M in net income for the fiscal year ending 2025 with a net profit margin of 3.0%.

What is Kemper Corporation 5.875% Fixed's operating profit margin?

Kemper Corporation 5.875% Fixed (KMPB) reported an operating income of $160.7M, resulting in an operating profit margin of 3.3%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Kemper Corporation 5.875% Fixed's gross profit and gross margin?

Kemper Corporation 5.875% Fixed (KMPB) generated $1.43B in gross profit for the year, representing a gross profit margin of 29.7%. This demonstrates the company's core pricing power and production efficiency.